Lionco Pharmaceutical Group Co.,Ltd.

¥5.44As of Sun 8 Nov 2026, 12:00 UTC
SSE:603669Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (8.18%)
Div yield —
ROE (18.29%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM —
TSR TTM (3.20%)
Mkt cap ¥3.876B
ROIC (3.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.92
8.77%
1.94%
Hold 5|5|11|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.06
0.06
0.07
16.37%
26.63%
16.85%
28.04%
Revenue¥M
358.1
376.0
374.6
364.2
10.80%
13.19%
11.98%
3.13%
Peers (US$581.0M)
Cap (US$)
PE
575.6M
26.66x
Capital
TTM
5Y
10Y
Leveragex
0.717
(0.328)
(0.288)
EBIT/Intx
2.472
0.089
0.092
Own earn%
(421.91)
(96.39)
(110.65)
Sh yield%
21.51
44.11
41.75
Owners
Insiders/Inst%
12.87
86.84
Short interest%
1.98
SBC / revenue%
2.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–23
$1 testx
−0.1
Incr. ROIC%
5